199 related articles for article (PubMed ID: 28499854)
1. Curcumin loading potentiates the chemotherapeutic efficacy of selenium nanoparticles in HCT116 cells and Ehrlich's ascites carcinoma bearing mice.
Kumari M; Ray L; Purohit MP; Patnaik S; Pant AB; Shukla Y; Kumar P; Gupta KC
Eur J Pharm Biopharm; 2017 Aug; 117():346-362. PubMed ID: 28499854
[TBL] [Abstract][Full Text] [Related]
2. Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles.
Kumari M; Purohit MP; Patnaik S; Shukla Y; Kumar P; Gupta KC
Eur J Pharm Biopharm; 2018 Sep; 130():185-199. PubMed ID: 29969665
[TBL] [Abstract][Full Text] [Related]
3. Pro-inflammatory macrophage polarization enhances the anti-cancer efficacy of self-assembled galactomannan nanoparticles entrapped with hydrazinocurcumin.
Kumari M; Purohit MP; Pahuja R; Patnaik S; Shukla Y; Kumar P; Gupta KC
Drug Deliv Transl Res; 2019 Dec; 9(6):1159-1188. PubMed ID: 31440985
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells.
Pal S; Choudhuri T; Chattopadhyay S; Bhattacharya A; Datta GK; Das T; Sa G
Biochem Biophys Res Commun; 2001 Nov; 288(3):658-65. PubMed ID: 11676493
[TBL] [Abstract][Full Text] [Related]
5. Chemoprotective and chemosensitizing properties of selenium nanoparticle (Nano-Se) during adjuvant therapy with cyclophosphamide in tumor-bearing mice.
Bhattacharjee A; Basu A; Biswas J; Sen T; Bhattacharya S
Mol Cell Biochem; 2017 Jan; 424(1-2):13-33. PubMed ID: 27696310
[TBL] [Abstract][Full Text] [Related]
6. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma.
Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV
Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973
[TBL] [Abstract][Full Text] [Related]
7. Synergistic anticancer efficacy of Bendamustine Hydrochloride loaded bioactive Hydroxyapatite nanoparticles: In-vitro, ex-vivo and in-vivo evaluation.
Thomas SC; Sharma H; Rawat P; Verma AK; Leekha A; Kumar V; Tyagi A; Gurjar BS; Iqbal Z; Talegaonkar S
Colloids Surf B Biointerfaces; 2016 Oct; 146():852-60. PubMed ID: 27455405
[TBL] [Abstract][Full Text] [Related]
8. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of a molecularly imprinted nanopreparation of 5-flurouracil against Ehrlich's carcinoma solid tumors grown in mice: Comparison to free 5-flurouracil.
Gardouh AR; Barakat BM; Qushawy MKE; El-Kazzaz AY; Sami MM; Zaitone SA
Chem Biol Interact; 2018 Nov; 295():52-63. PubMed ID: 29678497
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma.
Joseph MM; Aravind SR; George SK; Pillai KR; Mini S; Sreelekha TT
Colloids Surf B Biointerfaces; 2014 Apr; 116():219-27. PubMed ID: 24486833
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic potential of novel non-toxic nucleoside analogues on EAC ascitic tumour cells.
Barua A; Choudhury P; Maity JK; Mandal SB; Mandal S; Saha P
Free Radic Res; 2019 Jan; 53(1):57-67. PubMed ID: 30624093
[TBL] [Abstract][Full Text] [Related]
12. Folic acid and trastuzumab conjugated redox responsive random multiblock copolymeric nanocarriers for breast cancer therapy: In-vitro and in-vivo studies.
Kumar A; Lale SV; Aji Alex MR; Choudhary V; Koul V
Colloids Surf B Biointerfaces; 2017 Jan; 149():369-378. PubMed ID: 27846450
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle engineering enhances anticancer efficacy of andrographolide in MCF-7 cells and mice bearing EAC.
Roy P; Das S; Mondal A; Chatterji U; Mukherjee A
Curr Pharm Biotechnol; 2012 Dec; 13(15):2669-81. PubMed ID: 23072387
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
15. Apoptogenic effects of Tricholoma giganteum on Ehrlich's ascites carcinoma cell.
Chatterjee S; Biswas G; Chandra S; Saha GK; Acharya K
Bioprocess Biosyst Eng; 2013 Jan; 36(1):101-7. PubMed ID: 22684905
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of curcumin loaded polymer/lipid based nanoparticles and evaluation of their antitumor effects on MCF-7 cells.
Kumar SS; Mahesh A; Mahadevan S; Mandal AB
Biochim Biophys Acta; 2014 Jun; 1840(6):1913-22. PubMed ID: 24440669
[TBL] [Abstract][Full Text] [Related]
17. Dorzolamide synergizes the antitumor activity of mitomycin C against Ehrlich's carcinoma grown in mice: role of thioredoxin-interacting protein.
Ali BM; Zaitone SA; Shouman SA; Moustafa YM
Naunyn Schmiedebergs Arch Pharmacol; 2015 Dec; 388(12):1271-82. PubMed ID: 26264806
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles.
Chuah LH; Roberts CJ; Billa N; Abdullah S; Rosli R
Colloids Surf B Biointerfaces; 2014 Apr; 116():228-36. PubMed ID: 24486834
[TBL] [Abstract][Full Text] [Related]
19. The detection of curcumins' antitumoral effects via argyrophilic nucleolar organizing region-associated protein synthesis in mice with ehrlich's ascitic carcinoma.
Nisari M; Yilmaz S; Eroz R; Ertekin T; Bircan D; Ulger H
Bratisl Lek Listy; 2017; 118(1):61-65. PubMed ID: 28127985
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin.
Pal S; Bhattacharyya S; Choudhuri T; Datta GK; Das T; Sa G
Cancer Detect Prev; 2005; 29(5):470-8. PubMed ID: 16188398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
